ACAD

Acadia Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth↑ 9/10
  • Value↓ 3/10
Acadia Pharmaceuticals sales and earnings growth
ACAD Growth
Great
  • Revenue Y/Y↑ 11.87%
  • EPS Y/Y↑ 69.34%
  • FCF Y/Y↓ -33.11%
Acadia Pharmaceuticals gross and profit margin trends
ACAD Profitability
Good
  • Gross margin ↑ 91.70%
  • EPS margin↑ 36.50%
  • ROIC 5Y↑ 15.41%
Acadia Pharmaceuticals net debt vs free cash flow
ACAD Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Acadia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗